ISImatsuda as a potential predictor of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus
Among the IR indices, ISI<sub>matsuda</sub> demonstrated the strongest correlation and highest predictive value for MASLD in T2DM.
Authors
- S S Su (ORCID: https://orcid.org/0000-0001-5670-5139)
- Wen Zhu (ORCID: https://orcid.org/0000-0002-1870-9400)
- Yueqiu Wang
- Yiqiong Sun
- Xiaoyu Sun (ORCID: https://orcid.org/0000-0001-7434-0452)
- Xianqiang Zhou (ORCID: https://orcid.org/0000-0003-4736-9123)
- Yu Xia (ORCID: https://orcid.org/0000-0002-4571-6075)
- Hongru Li (ORCID: https://orcid.org/0000-0002-4916-2815)
- Jing Liu (ORCID: https://orcid.org/0000-0002-4118-442X)
- Weiwei Lin
- Yu Chen (ORCID: https://orcid.org/0000-0002-2825-6767)
- Mingchen Zhang (ORCID: https://orcid.org/0000-0002-1002-3009)
- Ruiting Shen
Institutions
- Zhejiang Chinese Medical University (CN)
- Shaoxing University (CN)
- Wenzhou Medical University (CN)
- Ningbo No. 2 Hospital (CN)
- Ningbo No.6 Hospital (CN)
- Northeastern University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/fmed.2025.1623808
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Hwa Mei Hospital, University of Chinese Academy of Sciences
- Science and Technology Program of Zhejiang Province